|
C13ORF34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.55239998212676E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5901999999588E-06 |
| Normal-vs-Stage2 |
7.756500E-03 |
| Normal-vs-Stage3 |
2.260900E-03 |
| Normal-vs-Stage4 |
4.321600E-03 |
| Stage1-vs-Stage2 |
2.276000E-01 |
| Stage1-vs-Stage3 |
9.359700E-02 |
| Stage1-vs-Stage4 |
9.849600E-01 |
| Stage2-vs-Stage3 |
6.895800E-01 |
| Stage2-vs-Stage4 |
2.804400E-01 |
| Stage3-vs-Stage4 |
1.308040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77020000272188E-08 |
| Normal-vs-AfricanAmerican |
1.244370E-04 |
| Normal-vs-Asian |
1.511670E-02 |
| Caucasian-vs-AfricanAmerican |
9.181400E-01 |
| Caucasian-vs-Asian |
1.333560E-01 |
| AfricanAmerican-vs-Asian |
1.544580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.27370000394478E-09 |
| Normal-vs-Female |
6.24439999999948E-05 |
| Male-vs-Female |
5.001200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.260300E-03 |
| Normal-vs-Extreme_Weight |
9.65160000000465E-05 |
| Normal-vs-Obese |
1.75830000004318E-06 |
| Normal-vs-Extreme_Obese |
1.617550E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.967600E-01 |
| Normal_Weight-vs-Obese |
1.222200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.597000E-01 |
| Extreme_Weight-vs-Obese |
5.420500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.673600E-01 |
| Obese-vs-Extreme_Obese |
2.736000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.562280E-04 |
| Normal-vs-Age(41-60Yrs) |
1.48649981213111E-10 |
| Normal-vs-Age(61-80Yrs) |
1.98117999999914E-05 |
| Normal-vs-Age(81-100Yrs) |
5.335800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.161600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.524000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.037600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.128400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.748220E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.795800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.16649995113494E-09 |
| Normal-VS-Type2 PRCC |
6.543700E-03 |
| Normal-VS-KIRP CIMP |
1.454380E-01 |
| Normal-VS-Unclassified PRCC |
2.216900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.670000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.924000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.458200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.733600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.132500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.556800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.169700E-04 |
| Normal-vs-N1 |
1.498630E-03 |
| Normal-vs-N2 |
8.480200E-01 |
| N0-vs-N1 |
5.742300E-02 |
| N0-vs-N2 |
1.518400E-01 |
| N1-vs-N2 |
1.349640E-01 |
|
|
